Pfizer CEO says he ‘wouldn’t worry much’ about monkeypox; cuts drug prices for low-income countries

Pfizer’s CEO said Wednesday that he “wouldn’t worry much” about a recent monkeypox outbreak that has seen cases surge in non-endemic countries.

Previous post Dick’s shares rally despite lower forecast; company says outdoor hobbies will outlast pandemic
Next post Justin Timberlake sells song catalog to fund backed by Blackstone in deal valued at $100 million